Showing results (121-130 of 141) with videos related to
Sort By:
Pageof 15
Seminars in Oncology|November 5, 1997
Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group studyD V Skarlos, G Aravantinos, P Kosmidis, et al.Thescientificworldjournal|November 14, 2013
Sonication: a valuable technique for diagnosis and treatment of periprosthetic joint infectionsD S Evangelopoulos, I P Stathopoulos, G P Morassi, et al.Oncology Research|November 4, 2000
Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancerA Giatromanolaki, M I Koukourakis, G P Stathopoulos, et al.Anticancer Research|April 13, 2001
Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapseA Giatromanolaki, E Sivridis, G P Stathopoulos, et al.Oncology Reports|August 4, 2005
Response to radiotherapy in brain metastases and survival of patients with non-small cell lung cancerDimosthenis Antoniou, Kostas Kyprianou, George P Stathopoulos, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: a multicenter phase II studyN Androulakis, C Kourousis, M A Dimopoulos, et al.Oncology Reports|September 25, 2008
Comparison of cisplatin-paclitaxel combination versus cisplatin-etoposide in patients with small-cell lung cancer: a Phase III studyJohn Dimitroulis, Angeliki Rapti, George P Stathopoulos, et al.Cancer Chemotherapy and Pharmacology|September 6, 2005
Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel: a phase II studyG P Stathopoulos, Ch Christodoulou, J Stathopoulos, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II studyG P Stathopoulos, K Syrigos, A Polyzos, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic CancerG P Stathopoulos, S K Rigatos, M A Dimopoulos, et al.Pageof 15